Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_assertion description "[Moreover, the detection of the TP53 R337H variant in our series and the fact that this variant has a founder effect in our population prompted us to suggest that all female breast cancer patients with clinical criteria for HBOC and negative for BRCA1/2 genes should be tested for the TP53 R337H variant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_assertion evidence source_evidence_literature NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_assertion SIO_000772 24884479 NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_assertion wasDerivedFrom befree-2016 NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_assertion wasGeneratedBy ECO_0000203 NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1187327.RAuyZUz8eUvBDH0r092Uo7h-AmONKr9hPF4SPb6ntsMHE130_provenance.